BL
MREO

BFSG LLC’s Mereo BioPharma MREO Stock Holding History

BFSG LLC’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,000
Closed -$3.5K – 697
2024
Q4 		$3.5K Hold
1,000
– – ﹤0.01% 576
2024
Q3 		$4.11K Hold
1,000
– – ﹤0.01% 551
2024
Q2 		$3.6K Hold
1,000
– – ﹤0.01% 541
2024
Q1 		$3.3K Buy
+1,000
New +$3.38K ﹤0.01% 569

Other funds holding MREO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

BFSG LLC's MREO Position: Q1 2025 in Review

BFSG LLC sold out of Mereo BioPharma (MREO) in Q1 2025, closing a stake of 1,000 shares — an estimated $3.5K sold.

BFSG LLC first reported a position in MREO in Q1 2024 and held it in 4 quarters. The position peaked at $4.11K in Q3 2024. 90 funds tracked by Wall St. Rank hold MREO as of Q1 2025.

  • BFSG LLC reported no remaining Mereo BioPharma position as of Q1 2025 after selling out during the quarter.
  • BFSG LLC sold 1,000 Mereo BioPharma shares in Q1 2025, an estimated $3.5K.
  • BFSG LLC first reported a position in Mereo BioPharma in Q1 2024 and held it in 4 quarters.
  • BFSG LLC's Mereo BioPharma position peaked at $4.11K in Q3 2024.
  • 90 funds tracked by Wall St. Rank held Mereo BioPharma as of Q1 2025.

Based on BFSG LLC's 13F filing for Q1 2025, filed 18 Apr 2025.